__timestamp | Alkermes plc | MiMedx Group, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 618789000 | 118223000 |
Thursday, January 1, 2015 | 628335000 | 187296000 |
Friday, January 1, 2016 | 745694000 | 245015000 |
Sunday, January 1, 2017 | 903374000 | 321139000 |
Monday, January 1, 2018 | 1094274000 | 359111000 |
Tuesday, January 1, 2019 | 1170947000 | 299255000 |
Wednesday, January 1, 2020 | 1038756000 | 248234000 |
Friday, January 1, 2021 | 1173751000 | 258615000 |
Saturday, January 1, 2022 | 1111795000 | 267841000 |
Sunday, January 1, 2023 | 1663405000 | 321477000 |
Unleashing insights
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding revenue trends is crucial. From 2014 to 2023, Alkermes plc and MiMedx Group, Inc. have shown distinct revenue trajectories. Alkermes plc, a leader in innovative medicines, has seen its revenue grow by approximately 169% over this period, peaking in 2023. This growth reflects its strategic focus on expanding its product portfolio and market reach. In contrast, MiMedx Group, Inc., specializing in regenerative biomaterials, experienced a more modest revenue increase of around 172%, with fluctuations reflecting market challenges and strategic shifts. Notably, 2018 marked a high point for MiMedx, with revenues reaching their peak before a subsequent decline. These insights underscore the dynamic nature of the industry and the importance of strategic adaptability in sustaining growth.
Comparing Revenue Performance: Novo Nordisk A/S or Alkermes plc?
AbbVie Inc. and Alkermes plc: A Comprehensive Revenue Analysis
Who Generates More Revenue? Bristol-Myers Squibb Company or Alkermes plc
Revenue Insights: Genmab A/S and MiMedx Group, Inc. Performance Compared
Comparing Revenue Performance: BioMarin Pharmaceutical Inc. or Alkermes plc?
Breaking Down Revenue Trends: Exelixis, Inc. vs MiMedx Group, Inc.
Lantheus Holdings, Inc. and Alkermes plc: A Comprehensive Revenue Analysis
Who Generates More Revenue? Ionis Pharmaceuticals, Inc. or Alkermes plc
Revenue Insights: Alkermes plc and Amphastar Pharmaceuticals, Inc. Performance Compared
Comparing Revenue Performance: MorphoSys AG or MiMedx Group, Inc.?
Revenue Insights: ImmunityBio, Inc. and MiMedx Group, Inc. Performance Compared
Revenue Insights: BioCryst Pharmaceuticals, Inc. and MiMedx Group, Inc. Performance Compared